JOHNSON & JOHNSON
JOHNSON & JOHNSON
- USD (-)
- Diferidos de 15 min - Acciones NYSE
Apertura: -
Cambio neto: -
Volumen: -
Mínimo: -
Máximo: -
Distancia Mín/Máx: -
Tipo: Acciones
Ticker: JNJ
ISIN:

Johnson & Johnson to Participate in Barclays Global Healthcare Conference

  • 45
Johnson & Johnson to Participate in Barclays Global Healthcare Conference

PR Newswire

NEW BRUNSWICK, N.J., Feb. 28, 2019 /PRNewswire/ -- Johnson & Johnson (NYSE: JNJ) will participate in the Barclays Global Healthcare Conference on Thursday, Mar. 14, at the Loews Miami Beach Hotel, Miami, FL.  Tom Cavanaugh, President, Oncology and Catherine Owen, President, Immunology will represent the Company in a session scheduled at 10:15 a.m. (Eastern Time).

This webcast will be available to investors and other interested parties by accessing the Johnson & Johnson website at www.investor.jnj.com.

A webcast replay will be available approximately two hours after the live webcast.

(PRNewsfoto/Johnson & Johnson)

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/johnson--johnson-to-participate-in-barclays-global-healthcare-conference-300804293.html

SOURCE Johnson & Johnson

PR Newswire
PR Newswire

PR Newswire es un distribuidor de comunicados de prensa con sede en la ciudad de Nueva York. El servicio se creó en 1954 para permitir que las empresas envíen comunicados de prensa electrónicamente a las organizaciones de noticias, al principio utilizando teleimpresores.